This inventor holds 1 USPTO granted patent. Top assignee: Cedars-Sinai Medical Center. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovator Gantsetseg Tumurkhuu: Revolutionary Approaches in Cancer Treatment
Introduction:
Gantsetseg Tumurkhuu, based in Los Angeles, CA, is a pioneering inventor dedicated to advancing cancer treatment methodologies. With a focus on enhancing patient outcomes, his innovative work addresses critical aspects of cancer and its metastasis.
Latest Patents:
Gantsetseg holds a significant patent titled "Intracellular IL-1 alpha peptide methods and compositions." This groundbreaking invention outlines methods and compositions aimed at treating cancer and mitigating cancer metastasis. Specifically, it presents the use of the IL-1α pro-piece peptide as a transformative approach in cancer therapies.
Career Highlights:
Currently, Gantsetseg contributes his expertise at Cedars-Sinai Medical Center, a prestigious institution renowned for its cutting-edge medical research and patient care. His role within this esteemed organization underscores his commitment to innovating within the field of oncology.
Collaborations:
Collaboration plays a vital role in Gantsetseg's work. He has teamed up with notable professionals such as Jargalsaikhan Dagvadorj and Moshe Arditi, fostering a collaborative environment that enhances the development of innovative cancer treatments.
Conclusion:
Gantsetseg Tumurkhuu stands at the forefront of cancer research and treatment innovation. His dedication, combined with a strong collaborative spirit, positions him as a remarkable inventor in the medical field, with the potential to significantly impact patient care and outcomes in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile